A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug‐binding proteins are associated through protein–protein interaction …
protein; however, drug‐binding proteins are associated through protein–protein interaction …
A network paradigm predicts drug synergistic effects using downstream protein-protein interactions
JL Wilson, E Steinberg, R Racz… - CPT …, 2022 - pubmed.ncbi.nlm.nih.gov
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug-binding proteins are associated through protein-protein interaction …
protein; however, drug-binding proteins are associated through protein-protein interaction …
[PDF][PDF] A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
JL Wilson, E Steinberg, R Racz, RB Altman, N Shah… - 2022 - qcb.ucla.edu
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug-binding proteins are associated through protein–protein interaction …
protein; however, drug-binding proteins are associated through protein–protein interaction …
A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
JL Wilson, E Steinberg, R Racz… - CPT …, 2022 - search.proquest.com
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug‐binding proteins are associated through protein–protein interaction …
protein; however, drug‐binding proteins are associated through protein–protein interaction …
A network paradigm predicts drug synergistic effects using downstream protein-protein interactions.
JL Wilson, E Steinberg, R Racz, RB Altman… - CPT …, 2022 - europepmc.org
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug-binding proteins are associated through protein-protein interaction …
protein; however, drug-binding proteins are associated through protein-protein interaction …
A network paradigm predicts drug synergistic effects using downstream protein-protein interactions.
JL Wilson, E Steinberg, R Racz… - CPT …, 2022 - escholarship.org
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug-binding proteins are associated through protein-protein interaction …
protein; however, drug-binding proteins are associated through protein-protein interaction …
A network paradigm predicts drug synergistic effects using downstream protein–protein interactions.
JL Wilson, E Steinberg, R Racz… - CPT …, 2022 - search.ebscohost.com
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug‐binding proteins are associated through protein–protein interaction …
protein; however, drug‐binding proteins are associated through protein–protein interaction …
[HTML][HTML] A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
JL Wilson, E Steinberg, R Racz, RB Altman… - CPT …, 2022 - ncbi.nlm.nih.gov
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug‐binding proteins are associated through protein–protein interaction …
protein; however, drug‐binding proteins are associated through protein–protein interaction …
[引用][C] A network paradigm predicts drug synergistic effects using downstream protein–protein interactions
JL Wilson, E Steinberg, R Racz, RB Altman, N Shah… - 2022 - europepmc.org
In some cases, drug combinations affect adverse outcome phenotypes by binding the same
protein; however, drug-binding proteins are associated through protein–protein interaction …
protein; however, drug-binding proteins are associated through protein–protein interaction …